Pressing Pause on Psychedelic Cash Analysing the Challenges in Psychedelic Drug Development Through Investment Trends Adrienne Rivlin Jess Sharpe Read more
Executive Insights Diagnostics, Tools and Personalized Medicine Autologous Cell Therapy: Key Challenges and Bioprocessing Innovations February 7, 2024
Executive Insights Healthcare Services Navigating Asia’s Regulatory Mosaic: Achieving Excellence in Generative AI for Healthcare January 26, 2024
Executive Insights Life Sciences & Pharma The Inflation Reduction Act: Implications for Drug Delivery Innovation January 3, 2024
Article Life Sciences & Pharma The New Map – Shifting geographic priorities for healthcare companies operating in Asia November 1, 2023